Osaki Citizen Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Lung cancer1 trial
• Ulcerative colitis1 trial

Phase

• Phase 2/32 trials
• Phase 31 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Amgen1 trial

Running trials

• Active, not recruiting

  A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

  NCT06311721· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source